Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Birth outcomes of pregnancies fathered by men with multiple sclerosis.

Lu E, Zhu F, Zhao Y, van der Kop M, Sadovnick AD, Synnes A, Dahlgren L, Traboulsee A, Tremlett H.

Mult Scler. 2014 Aug;20(9):1260-4. doi: 10.1177/1352458514521308. Epub 2014 Feb 5.

PMID:
24500603
2.

Birth outcomes in newborns fathered by men with multiple sclerosis exposed to disease-modifying drugs.

Lu E, Zhu F, Zhao Y, van der Kop M, Synnes A, Dahlgren L, Sadovnick AD, Traboulsee A, Tremlett H.

CNS Drugs. 2014 May;28(5):475-82. doi: 10.1007/s40263-014-0154-6.

PMID:
24643915
3.

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.

Pecori C, Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pastò L, Razzolini L, Sturchio A, De Giglio L, Pozzilli C, Paolicelli D, Trojano M, Marrosu MG, Patti F, Mancardi GL, Solaro C, Totaro R, Tola MR, De Luca G, Lugaresi A, Moiola L, Martinelli V, Comi G, Amato MP; MS Study Group of the Italian Neurological Society.

BMC Neurol. 2014 May 26;14:114. doi: 10.1186/1471-2377-14-114.

4.

Birth hospitalization in mothers with multiple sclerosis and their newborns.

Lu E, Zhao Y, Zhu F, van der Kop ML, Synnes A, Dahlgren L, Sadovnick AD, Sayao AL, Tremlett H; British Columbia Multiple Sclerosis Clinic Neurologists.

Neurology. 2013 Jan 29;80(5):447-52. doi: 10.1212/WNL.0b013e31827f0efc. Epub 2013 Jan 9.

5.

Paternal age, placental weight and placental to birthweight ratio: a population-based study of 590,835 pregnancies.

Strøm-Roum EM, Haavaldsen C, Tanbo TG, Eskild A.

Hum Reprod. 2013 Nov;28(11):3126-33. doi: 10.1093/humrep/det299. Epub 2013 Jul 19.

PMID:
23873147
6.

Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-α Agents Before Conception.

Larsen MD, Friedman S, Magnussen B, Nørgård BM.

Am J Gastroenterol. 2016 Nov;111(11):1608-1613. doi: 10.1038/ajg.2016.405. Epub 2016 Sep 13.

PMID:
27619836
7.

Neonatal and delivery outcomes in women with multiple sclerosis.

van der Kop ML, Pearce MS, Dahlgren L, Synnes A, Sadovnick D, Sayao AL, Tremlett H.

Ann Neurol. 2011 Jul;70(1):41-50. doi: 10.1002/ana.22483. Epub 2011 Jun 27.

8.

No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.

Weber-Schoendorfer C, Hoeltzenbein M, Wacker E, Meister R, Schaefer C.

Rheumatology (Oxford). 2014 Apr;53(4):757-63. doi: 10.1093/rheumatology/ket390. Epub 2013 Dec 24.

PMID:
24369411
9.

Birth Outcome of Children Fathered by Men Treated with Systemic Corticosteroids during the Conception Period - A Cohort Study based on Nationwide Data.

Larsen MD, Friedman S, Magnussen B, Nørgård BM.

Basic Clin Pharmacol Toxicol. 2017 Aug 14. doi: 10.1111/bcpt.12857. [Epub ahead of print]

PMID:
28804964
10.

Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340 000 pregnancies using Norwegian population-based databases.

Engeland A, Bjørge T, Daltveit AK, Skurtveit S, Vangen S, Vollset SE, Furu K.

Br J Clin Pharmacol. 2013 Apr;75(4):1134-41. doi: 10.1111/j.1365-2125.2012.04426.x.

11.

Characteristics of multiple sclerosis in aboriginals living in British Columbia, Canada.

Saeedi J, Rieckmann P, Yee I, Tremlett H; UBC MS clinic neurologists.

Mult Scler. 2012 Sep;18(9):1239-43. doi: 10.1177/1352458512436595. Epub 2012 Mar 1.

PMID:
22383230
12.

No effect of parental age on risk of multiple sclerosis: a population-based study.

Ramagopalan SV, Dyment DA, Guimond C, Yee IM, Ebers GC, Sadovnick AD.

Neuroepidemiology. 2010;34(2):106-9. doi: 10.1159/000268822. Epub 2009 Dec 24.

PMID:
20051693
13.

Labor induction and augmentation in women with multiple sclerosis.

Lu E, Zhu F, van der Kop M, Dahlgren L, Synnes A, Sadovnick A, Traboulsee A, Tremlett H; British Columbia Multiple Sclerosis Clinic Neurologists.

Mult Scler. 2013 Aug;19(9):1182-9. doi: 10.1177/1352458512474090. Epub 2013 Feb 5.

PMID:
23386429
14.

Paternal metabolic and cardiovascular risk factors for fetal growth restriction: a case-control study.

Hillman S, Peebles DM, Williams DJ.

Diabetes Care. 2013 Jun;36(6):1675-80. doi: 10.2337/dc12-1280. Epub 2013 Jan 11.

15.

Does multiple sclerosis increase risk of adverse pregnancy outcomes? A population-based study.

Chen YH, Lin HL, Lin HC.

Mult Scler. 2009 May;15(5):606-12. doi: 10.1177/1352458508101937. Epub 2009 Mar 24.

PMID:
19318510
16.

Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression.

Zhang T, Kingwell E, De Jong HJ, Zhu F, Zhao Y, Carruthers R, Petkau J, Gustafson P, Oger J, Tremlett H.

Pharmacoepidemiol Drug Saf. 2016 Oct;25(10):1150-1159. doi: 10.1002/pds.4031. Epub 2016 May 23.

PMID:
27211481
17.

Outcomes of pregnancies fathered by solid-organ transplant recipients exposed to mycophenolic acid products.

Jones A, Clary MJ, McDermott E, Coscia LA, Constantinescu S, Moritz MJ, Armenti VT.

Prog Transplant. 2013 Jun;23(2):153-7. doi: 10.7182/pit2013636.

PMID:
23782663
18.

Children of chronically ill parents: Relationship between parental multiple sclerosis and childhood developmental health.

Razaz N, Joseph KS, Boyce WT, Guhn M, Forer B, Carruthers R, Marrie RA, Tremlett H.

Mult Scler. 2016 Oct;22(11):1452-1462. Epub 2015 Dec 18.

19.

Paternal contribution to small for gestational age babies: a multicenter prospective study.

McCowan LM, North RA, Kho EM, Black MA, Chan EH, Dekker GA, Poston L, Taylor RS, Roberts CT.

Obesity (Silver Spring). 2011 May;19(5):1035-9. doi: 10.1038/oby.2010.279. Epub 2010 Dec 2.

20.

Obstetric and neonatal outcome of pregnancies fathered by males on immunosuppression after solid organ transplantation.

Morken NH, Diaz-Garcia C, Reisaeter AV, Foss A, Leivestad T, Geiran O, Hervás D, Brännström M.

Am J Transplant. 2015 Jun;15(6):1666-73. doi: 10.1111/ajt.13159. Epub 2015 Apr 13.

Supplemental Content

Support Center